ECONOMIC IMPACT OF SURGICAL SEALANT USE VERSUS STANDARD OF CARE IN PATIENTS UNDERGOING AORTIC REPAIR AND RECONSTRUCTION: A BRAZILIAN COST-CONSEQUENCE ANALYSIS

Author(s)

Gresse S1, Ramirez M2, Martinez N3, Gil Ocanha Silva J1
1Baxter Hospitalar, São Paulo, SP, Brazil, 2Baxter Healthcare Corporation, Deerfield, IL, USA, 3Baxter Brazil, São Paulo, IL, Brazil

OBJECTIVES : To develop a Cost-Consequence analysis based on the estimated cost savings when Coseal surgical sealant (CSS) is used to seal anastomotic closures during aortic reconstruction and repair procedures.

METHODS : A Cost-Consequence Model was developed to compare resources utilization in patients who receive sutures (Standard of Care = SoC) vs. SoC plus CSS in aortic surgeries. Clinical data, such as ICU stay, length of hospitalization, Rethoracotomy, use of red blood cells (RBC) and fresh frozen plasma (FFP) has been obtained from Natour 2012. Costs have been obtained from Brazilian literature; local official sources and economic data from previous years (2016-17) has been adjusted for annual inflation. Model results include savings per patient and total budget impact if CSS would be regularly used in patients undergoing aortic surgeries.

RESULTS : CSS+SoC shows dominant versus SoC and sensitivity analysis demonstrates overall savings based on adjusted clinical parameters. Considering overall costs, treatment with CSS+SoC represents savings around -USD $7,106.23 per patient due to less days of ICU (6.4 vs. 4.3 days), hospital length of stay (21.0 vs. 16.1 days), lower incidence of Rethoracotomy (11.1% vs. 2.1%), less use of RBC (5 vs. 3.6 un) and less use of FFP (3 vs. 2.1 un). Total budget impact is -USD $710,623.44 per 100 surgeries that use CSS+SoC in the lieu of SoC. Acquisition costs (USD$ 661.40) per surgery have been compensated by savings per patient in complication and the utilization of health resources.

CONCLUSIONS : Surgical complications and use of health resources are main drivers to increased costs. This analysis demonstrates that CSS+SoC is a potentially cost-saving decision (-USD $7,106.23 per patient) that impacts the institutional budget in a positive way. Savings could be explained by lower incidence of complications, especially avoided surgical re-intervention for bleeding repairing, use of blood products and hospital length of stay.

Conference/Value in Health Info

2020-05, ISPOR 2020, Orlando, FL, USA

Value in Health, Volume 23, Issue 5, S1 (May 2020)

Code

PCV41

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Cardiovascular Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×